1145415004: Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual therapeutic moiety\Co-careldopa\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing dihydroxyphenylalanine decarboxylase inhibitor\Product containing carbidopa\Product containing carbidopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing dihydroxyphenylalanine decarboxylase inhibitor\Product containing carbidopa\Product containing carbidopa and levodopa\Co-careldopa\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing dihydroxyphenylalanine decarboxylase inhibitor\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing carbidopa\Product containing carbidopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing carbidopa\Product containing carbidopa and levodopa\Co-careldopa\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing levodopa\Product containing levodopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing levodopa\Product containing carbidopa and levodopa\Co-careldopa\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing levodopa\Product containing carbidopa and levodopa\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing carbidopa\Product containing carbidopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing carbidopa\Product containing carbidopa and levodopa\Co-careldopa\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing levodopa\Product containing levodopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing levodopa\Product containing carbidopa and levodopa\Co-careldopa\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing levodopa\Product containing carbidopa and levodopa\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing carbidopa\Product containing carbidopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing carbidopa\Product containing carbidopa and levodopa\Co-careldopa\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing levodopa\Product containing levodopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing levodopa\Product containing carbidopa and levodopa\Co-careldopa\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing levodopa\Product containing carbidopa and levodopa\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Product manufactured as oral dose form\Product containing levodopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)
\Medicinal product\Product manufactured as oral dose form\Product containing carbidopa in oral dose form (medicinal product form)\Product containing carbidopa and levodopa in oral dose form (medicinal product form)\Product containing only carbidopa and levodopa in oral dose form (medicinal product form)\Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

4545858010 Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

4545859019 Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Plays role	Antiparkinson therapeutic role	true	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has unit of presentation	Tablet	true	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Is a	Product containing only carbidopa and levodopa in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has manufactured dose form	Prolonged-release oral tablet	true	Inferred relationship	Existential restriction modifier
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance	Levodopa	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has precise active ingredient	Levodopa	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has precise active ingredient	Carbidopa	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	Has basis of strength substance	Carbidopa	true	Inferred relationship	Existential restriction modifier	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
4545858010	Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
4545859019	Carbidopa 50 mg and levodopa 200 mg prolonged-release oral tablet	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module